IOPtima
Surgical Ophthalmic Laser Devices and Accessories
Company Overview
Snapshot
Founded in January 2005, IOPtima operates with 1–10 employees. The company has raised $7.2 million across one funding round from 3 investors. IOPtima was acquired by Chengdu Kanghong Pharmaceutical Group in September 2018.
Business overview
IOPtima is a company focused on developing minimally invasive and innovative surgical ophthalmic devices. Its core product, the IOPtimate, is a surgical system designed for glaucoma treatment, utilizing CO2 laser technology to reduce internal eye pressure without ocular penetration. The company also offers patented eye drops for ocular surface diseases. IOPtima serves the healthcare market, specifically targeting hospitals, clinics, and healthcare providers within the ophthalmology and medical devices sectors.
Strategic signal
In September 2018, Chengdu Kanghong Pharmaceutical Group solidified its ownership of IOPtima, marking a significant strategic integration for the Israeli medical device company. This acquisition indicates a strong validation of IOPtima's ophthalmic technology and provides a clear signal of its future direction under the umbrella of a larger pharmaceutical group, likely expanding its market reach and product development capabilities.
Company Intelligence Q&A
- What is IOPtima's primary focus?
- IOPtima specializes in developing minimally invasive and innovative surgical ophthalmic devices, including its flagship CO2 laser system for glaucoma treatment and patented eye drops for ocular surface diseases.
- When was IOPtima acquired?
- IOPtima was acquired by Chengdu Kanghong Pharmaceutical Group in September 2018.
- What was a key product launch for IOPtima in 2017?
- In October 2017, IOPtima launched Lipitear phospholipid microemulsion, and in July 2017, it launched the iLid CO2 laser kit for blepharoplasty.
- Which investors participated in IOPtima's funding round?
- In November 2015, IOPtima received funding from investors including Infinity China.
- When did IOPtima receive regulatory approval for its IOPtiMate System in Canada?
- In December 2015, Bio Light's IOPtiMate System received regulatory approval in Canada.